Next Article in Journal
Coffee with Cordyceps militaris and Hericium erinaceus Fruiting Bodies as a Source of Essential Bioactive Substances
Previous Article in Journal
Computational Design of Novel Tau-Tubulin Kinase 1 Inhibitors for Neurodegenerative Diseases
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Singh et al. Nanotechnology-Aided Advancement in Combating the Cancer Metastasis. Pharmaceuticals 2023, 16, 899

1
Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida 203201, India
2
Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Kherva 384012, India
3
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand
4
Chandigarh Engineering College, Jhanjeri, Mohali 140307, India
*
Authors to whom correspondence should be addressed.
These authors contributed equally to the manuscript.
Pharmaceuticals 2024, 17(7), 954; https://doi.org/10.3390/ph17070954
Submission received: 2 July 2024 / Accepted: 8 July 2024 / Published: 17 July 2024

Addition of Reference

In the original publication [1], “Nanotechnology-Aided Advancement in Combating the Cancer Metastasis”, Reference [136] (see [2]) “Avula, L.R.; Grodzinski, P. Nanotechnology-aided advancement in the combating of cancer metastasis. Cancer Metastasis Rev. 2022, 41, 383–404. https://doi.org/10.1007/s10555-022-10025-7” was not cited. The citation has now been inserted into Section 9 “Every year, almost 500 million doses of these two vaccines were administered in the United States alone. mRNA-based cancer therapies will become accessible shortly due to their efficacy as a delivery mechanism [134–136]”. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

References

  1. Singh, A.K.; Malviya, R.; Prajapati, B.; Singh, S.; Yadav, D.; Kumar, A. Nanotechnology-Aided Advancement in Combating the Cancer Metastasis. Pharmaceuticals 2023, 16, 899. [Google Scholar] [CrossRef] [PubMed]
  2. Avula, L.R.; Grodzinski, P. Nanotechnology-aided advancement in the combating of cancer metastasis. Cancer Metastasis Rev. 2022, 41, 383–404. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Singh, A.K.; Malviya, R.; Prajapati, B.; Singh, S.; Yadav, D.; Kumar, A. Correction: Singh et al. Nanotechnology-Aided Advancement in Combating the Cancer Metastasis. Pharmaceuticals 2023, 16, 899. Pharmaceuticals 2024, 17, 954. https://doi.org/10.3390/ph17070954

AMA Style

Singh AK, Malviya R, Prajapati B, Singh S, Yadav D, Kumar A. Correction: Singh et al. Nanotechnology-Aided Advancement in Combating the Cancer Metastasis. Pharmaceuticals 2023, 16, 899. Pharmaceuticals. 2024; 17(7):954. https://doi.org/10.3390/ph17070954

Chicago/Turabian Style

Singh, Arun Kumar, Rishabha Malviya, Bhupendra Prajapati, Sudarshan Singh, Deepika Yadav, and Arvind Kumar. 2024. "Correction: Singh et al. Nanotechnology-Aided Advancement in Combating the Cancer Metastasis. Pharmaceuticals 2023, 16, 899" Pharmaceuticals 17, no. 7: 954. https://doi.org/10.3390/ph17070954

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop